Page last updated: 2024-12-04

cuminaldehyde

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

cuminaldehyde : A member of the class of benzaldehydes that is benzaldehyde substituted by an isopropyl group at position 4. It is a component of essential oils from Cumin and exhibits insecticidal activities. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID326
CHEMBL ID161577
CHEBI ID28671
SCHEMBL ID87226
MeSH IDM0050179

Synonyms (88)

Synonym
AC-2430
cuminyl aldehyde
cumic aldehyde
nsc4886
p-isopropylbenzaldehyde
benzaldehyde, 4-(1-methylethyl)-
wln: vhr dy1 & 1
benzaldehyde, p-isopropyl-
nsc-4886
p-isopropyl benzaldehyde
4-(1-methylethyl)benzaldehyde
4-isopropylbenzenecarboxylate
nsc 4886
ai3-01853
fema no. 2341
einecs 204-516-9
p-isopropylbenzenecarboxaldehyde
brn 0636547
p-cuminic aldehyde
inchi=1/c10h12o/c1-8(2)10-5-3-9(7-11)4-6-10/h3-8h,1-2h
cuminic aldehyde
cumaldehyde
p-cumic aldehyde
4-isopropylbenzaldehyde
C06577
122-03-2
cuminal
cuminaldehyde
cuminaldehyde, >=98%, fcc, fg
cuminaldehyde, 98%
p-isopropylbenzaldehyde, f
bdbm50139366
BMSE000508
chebi:28671 ,
4-isopropyl-benzaldehyde
CHEMBL161577 ,
I0168
4-propan-2-ylbenzaldehyde
AKOS000119738
A804831
NCGC00248148-01
4-(propan-2-yl)benzaldehyde
4-07-00-00723 (beilstein handbook reference)
ec 204-516-9
unii-o0893nc35f
o0893nc35f ,
4-(methylethyl)benzaldehyde
tox21_300712
cas-122-03-2
dtxsid9021974 ,
dtxcid601974
NCGC00257518-01
FT-0624115
S5089
SCHEMBL87226
4-(isopropyl)benzaldehyde
4isopropylbenzaldehyde
p-iso-propylbenzaldehyde
4(isopropyl)benzaldehyde
(4-isopropyl-phenyl)-methanone
4-isopropyl benzaldehyde
4(2-propyl)-benzaldehyde
cuminaldehyde [fhfi]
cuminaldehyde [mi]
4-i-propylbenzaldehyde
cuminic aldehyde [fcc]
4-ipr-benzaldehyde
p-(1-methylethyl)benzaldehyde
cumin aldehyde
4-isopropylphenylcarboxaldehyde
cumal
W-108440
mfcd00006953
CS-0015770
F2190-0632
cuminaldehyde, analytical standard
cuminal p-(1-methylethyl)benzaldehyde
p-isopropyl-benzaldehyde
cuminaldehyd
cuminadlehyde
Q419952
HY-Y0790
AS-12957
STL194065
CCG-266191
D70801
EN300-19901
Z104476006

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" In addition, cytotoxicity assays on PC12 cells showed that cuminaldehyde is a nontoxic compound, treatment with cuminaldehyde throughout α-SN fibrillation showed no toxic effects on the cells."( Cuminaldehyde as the Major Component of Cuminum cyminum, a Natural Aldehyde with Inhibitory Effect on Alpha-Synuclein Fibrillation and Cytotoxicity.
Aliakbari, F; Fassihi, A; Morshedi, D; Pan-Montojo, F; Pérez-Sánchez, H; Tayaranian-Marvian, A, 2015
)
2.1

Bioavailability

Cuminaldehyde self-emulsified nanoemulsion (CuA-SEN) was prepared and optimised to improve its oral bioavailability and antihepatotoxicity.

ExcerptReferenceRelevance
"Cuminaldehyde self-emulsified nanoemulsion (CuA-SEN) was prepared and optimised to improve its oral bioavailability and antihepatotoxicity."( Novel cuminaldehyde self-emulsified nanoemulsion for enhanced antihepatotoxicity in carbon tetrachloride-treated mice.
Adu-Frimpong, M; Firempong, CK; Lijun, Z; Mukhtar, YM; Omari-Siaw, E; Qiuyu, W; Xu, X; Yang, Q; Yu, J, 2019
)
2.44
" In-vitro drug release of CuA-SEN significantly increased with an oral relative bioavailability of 171."( Novel cuminaldehyde self-emulsified nanoemulsion for enhanced antihepatotoxicity in carbon tetrachloride-treated mice.
Adu-Frimpong, M; Firempong, CK; Lijun, Z; Mukhtar, YM; Omari-Siaw, E; Qiuyu, W; Xu, X; Yang, Q; Yu, J, 2019
)
0.99
"These findings showed that the improved bioavailability of cuminaldehyde via SEN provided an effective approach for enhancing antioxidation, anti-inflammation and antihepatotoxicity of the drug."( Novel cuminaldehyde self-emulsified nanoemulsion for enhanced antihepatotoxicity in carbon tetrachloride-treated mice.
Adu-Frimpong, M; Firempong, CK; Lijun, Z; Mukhtar, YM; Omari-Siaw, E; Qiuyu, W; Xu, X; Yang, Q; Yu, J, 2019
)
1.24
" The PASS online and SwissADME programmes were used for the prediction of biological activities and oral bioavailability of cuminaldehyde."( Cuminaldehyde potentiates the antimicrobial actions of ciprofloxacin against Staphylococcus aureus and Escherichia coli.
Almeida, VSS; Carvalho Júnior, AR; da Silveira, BC; de Araújo, TS; de Oliveira, NMT; de Souza, CD; Fernandes, ES; Ferro, TAF; Gonzaga, LF; Maria-Ferreira, D; Martins, WC; Mendes, SJF; Monteiro-Neto, V; Pessoa, JFV; Pontes, JP; Santos, DM; Sousa, NCF, 2020
)
2.21
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
insecticideStrictly, a substance intended to kill members of the class Insecta. In common usage, any substance used for preventing, destroying, repelling or controlling insects.
volatile oil componentAny plant metabolite that is found naturally as a component of a volatile oil.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
benzaldehydesAny arenecarbaldehyde that consists of a formyl substituted benzene ring and its substituted derivatives thereof.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
p-cymene degradation1421
p-cymene degradation to p-cumate39

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
retinoid X nuclear receptor alphaHomo sapiens (human)Potency43.64120.000817.505159.3239AID1159527; AID1159531
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Polyphenol oxidase 2Agaricus bisporusIC50 (µMol)75.00000.03403.987110.0000AID1799672
TyrosinaseHomo sapiens (human)IC50 (µMol)50.00000.02304.459310.0000AID213388
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (11)

Processvia Protein(s)Taxonomy
melanin biosynthetic process from tyrosineTyrosinaseHomo sapiens (human)
eye pigment biosynthetic processTyrosinaseHomo sapiens (human)
visual perceptionTyrosinaseHomo sapiens (human)
cell population proliferationTyrosinaseHomo sapiens (human)
response to UVTyrosinaseHomo sapiens (human)
response to blue lightTyrosinaseHomo sapiens (human)
response to vitamin DTyrosinaseHomo sapiens (human)
melanin biosynthetic processTyrosinaseHomo sapiens (human)
thymus developmentTyrosinaseHomo sapiens (human)
response to cAMPTyrosinaseHomo sapiens (human)
pigmentationTyrosinaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (5)

Processvia Protein(s)Taxonomy
tyrosinase activityTyrosinaseHomo sapiens (human)
copper ion bindingTyrosinaseHomo sapiens (human)
protein bindingTyrosinaseHomo sapiens (human)
identical protein bindingTyrosinaseHomo sapiens (human)
protein homodimerization activityTyrosinaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (7)

Processvia Protein(s)Taxonomy
cytoplasmTyrosinaseHomo sapiens (human)
lysosomeTyrosinaseHomo sapiens (human)
Golgi-associated vesicleTyrosinaseHomo sapiens (human)
melanosome membraneTyrosinaseHomo sapiens (human)
melanosomeTyrosinaseHomo sapiens (human)
intracellular membrane-bounded organelleTyrosinaseHomo sapiens (human)
perinuclear region of cytoplasmTyrosinaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1799672Inhibition Assay from Article 10.1080/14756360310001613094: \\Inhibitory effects on mushroom tyrosinase by some alkylbenzaldehydes.\\2003Journal of enzyme inhibition and medicinal chemistry, Dec, Volume: 18, Issue:6
Inhibitory effects on mushroom tyrosinase by some alkylbenzaldehydes.
AID293934Inhibition of pieris rapae Phenoloxidase2007Bioorganic & medicinal chemistry, Mar-01, Volume: 15, Issue:5
3D-QSAR and molecular docking studies of benzaldehyde thiosemicarbazone, benzaldehyde, benzoic acid, and their derivatives as phenoloxidase inhibitors.
AID468443Inhibition of human FAAH at 1 uM2009Bioorganic & medicinal chemistry letters, Dec-01, Volume: 19, Issue:23
Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitors.
AID213388Inhibitory activity was evaluated against the oxidation of L-3,4-dihydroxyphenylalanine (L-DOPA) catalyzed by mushroom tyrosinase2004Bioorganic & medicinal chemistry letters, Feb-09, Volume: 14, Issue:3
2-hydroxy-4-isopropylbenzaldehyde, a potent partial tyrosinase inhibitor.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (53)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (1.89)18.7374
1990's2 (3.77)18.2507
2000's6 (11.32)29.6817
2010's23 (43.40)24.3611
2020's21 (39.62)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 41.16

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index41.16 (24.57)
Research Supply Index3.99 (2.92)
Research Growth Index5.45 (4.65)
Search Engine Demand Index57.12 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (41.16)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.89%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other52 (98.11%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]